← Eichor
Study identifier: NCT05508256 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction

Condition: Atrial Fibrillation · Heart Failure With Preserved Ejection Fraction · Heart Failure With Mildly Reduced Ejection Fraction  ·  Sponsor: Charite University, Berlin, Germany

PhasePhase 4
Planned participants1548
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The objective of CABA-HFPEF is to test whether catheter ablation (CA) for atrial fibrillation (AF) can prevent adverse cardiovascular outcomes in patients with heart failure with preserved (HFpEF) or mildly reduced ejection fraction (HFmrEF).

This description comes directly from the study's public registry record.

Talk to the study team

Abdul Parwani, Dr.  ·  +4930450565383  ·  caba_hfpef@charite.de

Always discuss trial participation with your own doctor first.

Locations (1)

Charité University Medicine Berlin, Campus Virchow KlinikumBerlin, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05508256